2013 - 2016 Development of multi-peptide tumor vaccine for renal cell carcinoma
2012 - 2015 Identification of cancer-derived peptides as potential candidates for the development of anti-cancer vaccines for prostate cancer patients
2010 - 2012 Development of tailor made peptide vaccines for renal cell carcinoma
2007 - 2008 Development of tailor-madepeptide vaccines for renal eell carcinoma
Show all
Papers (100):
Mamoru Harada, Hitoshi Kotani, Yuichi Iida, Ryosuke Tanino, Takafumi Minami, Yoshihiro Komohara, Kazuhiro Yoshikawa, Hirotsugu Uemura. Hypoxia-related carbonic anhydrase 9 induces serpinB9 expression in cancer cells and apoptosis in T cells via acidosis. Cancer science. 2024
Wataru Fukuokaya, Yuhei Koike, Yuji Yata, Kazumasa Komura, Taizo Uchimoto, Takuya Tsujino, Masanobu Saruta, Kiyoshi Takahara, Kazutoshi Fujita, Takafumi Minami, et al. Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study. International journal of urology : official journal of the Japanese Urological Association. 2023
Koji Miki, Kazutoshi Fujita, Ken Kuwahara, Shogo Adomi, Takafumi Minami, Masahiro Nozawa, Kazuhiro Yoshimura, Misa Kojima, Osamu Maenishi, Hirotsugu Uemura. A case of neuroendocrine tumor at the external urethral meatus after total cystectomy. IJU case reports. 2023. 6. 6. 424-427
Takafumi Minami, Kazutoshi Fujita, Mamoru Hashimoto, Mitsuhisa Nishimoto, Shogo Adomi, Eri Banno, Masahiro Nozawa, Kazuhiro Nose, Kazuhiro Yoshimura, Masahiro Inada, et al. External beam radiotherapy combination is a risk factor for bladder cancer in patients with prostate cancer treated with brachytherapy. World journal of urology. 2023
2023/04 - 現在 Department of Urology, Kindai University School of Medicine
2020/04 - 2023/03 Department of Urology, Kindai University School of Medicine
2014 - 2020/03 Kindai University Faculty of Medicine
2007 - 2013 Kindai University Faculty of Medicine
Awards (1):
2015/03 - EAU Best Poster A phase-II study of peptide vaccines and dexamethasone vs dexamethasone alone for chemotherapy-naive castration resistant prostate cancer- a final report